| BASF Beauty Care Solutions France S.A.S. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110244063 | NOVEL SEBUM SECRETION INHIBITORY AGENT - The present invention relates to a novel sebum secretion inhibitor and use thereof for the production of cosmetic and pharmaceutical, notably dermatological, compositions, intended for preventing and/or reducing the secretion of sebum and notably of squalene. | 10-06-2011 |
| 20110237551 | Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions - The invention relates to the use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions, specifically to the use of at least one compound derived from para-coumaric acid having a general formula (I) below: | 09-29-2011 |
| 20110052739 | Active Ingredient That Stimulates the Proliferation and/or Activity of Fibroblasts - The invention relates to a novel active ingredient that stimulates the proliferation and/or the activity of fibroblasts and also to its applications in the cosmetic or pharmaceutical, in particular dermatological, field. In particular, the active ingredient according to the invention comprises a combination of at least one | 03-03-2011 |
| 20110014175 | STIMULATION OF THE SYNTHESIS OF THE ACTIVITY OF AN ISOFORM OF LYSL OXIDASE-LIKE LOXL FOR STIMULATING THE FORMATION OF ELASTIC FIBRES - The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. | 01-20-2011 |
| 20110008394 | ACTIVE SUBSTANCES THAT INCREASE THE ACTIVATION THRESHOLD OF IMMUNE CELLS - The present invention relates to the use of active substances that increase the activation threshold of immune cell as an active principle for the preparation of a cosmetic or pharmaceutical composition, especially a dermatological composition. The invention also relates to a method for screening such active substances. | 01-13-2011 |
| 20100316743 | INHIBITION OF THE FORMATION OF AGEs - The present invention relates to the use of an active substance that promotes the inhibition of the formation of AGEs, for preparing a composition to prevent and/or combat the reduction in elastic and plastic properties of tissues, and in particular of the skin, for inhibiting the formation of AGEs, or for preventing and/or combating glycation of proteins in the skin. | 12-16-2010 |
| 20100297765 | METHOD FOR PRODUCING LANGERHANS CELLS OR INTERSTITIAL DENDRITIC CELLS OR BOTH FROM CD14+ MONOCYTES - The present invention relates to a method for preparing Langerhans cells or interstitial dendritic cells or both from CD14 | 11-25-2010 |
| 20100272699 | MC-1R, MC-2R, and/or OPIOID RECEPTORS STIMULATION - The invention concerns active substances modulating the expression of the receptors of the products of the POMC gene (MC-IR, MC-2R, and the μ opioid receptor), and possibly modulating the expression of POMC in cutaneous cells, notably to modulate the proliferation and differentiation of epidermal cells in order to re-epithelial, maintain innervation, irrigate the skin, or to fight against aging, or to modulate pigmentation independently or not of cutaneous aging. The invention also concerns a method of screening such active substances. | 10-28-2010 |
| 20100209407 | MC-1R, MC-2R, AND/OR MU OPIOID RECEPTORS MODULATION - The invention concerns active substances modulating the expression of the receptors of the products of the POMC gene (MC-IR, MC-2R, and the μ opioid receptor), and possibly modulating the expression of POMC in cutaneous cells, notably to modulate the proliferation and differentiation of epidermal cells in order to re-epithelial, maintain innervation, irrigate the skin, or restore normal pigmentation, or to fight against aging, or to modulate pigmentation independently or not of cutaneous aging. The invention also concerns a method of screening such active substances. | 08-19-2010 |
| 20100203175 | DEGLYCATION OF AGEs - The invention relates to the use, as an active ingredient, of at least one substance that promotes the deglycation of AGEs for preparing a composition, especially for limiting the presence of AGEs in a tissue. | 08-12-2010 |
| 20100143512 | NOVEL SEBUM SECRETION INHIBITORY AGENT - The present invention relates to a novel sebum secretion inhibitor and use thereof for the production of cosmetic and pharmaceutical, notably dermatological, compositions, intended for preventing and/or reducing the secretion of sebum and notably of squalene. | 06-10-2010 |
| 20100080787 | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION COMPRISING AN ENZYME WHICH IS INSOLUBLE IN AN AQUEOUS MEDIUM AS WELL AS ITS USES - The invention relates to a cosmetic or dermopharmaceutical composition, as well as these uses. | 04-01-2010 |
| 20100047361 | Active Principle which is capable of inducing the conversion of inactive TGFb-Latent into active TGFb - The invention relates to active principles which are capable of inducing the conversion of inactive TGFb-Latent into active TGFb. The invention relates in particular to the use of such an extract for the manufacture of a composition for increasing the concentration of active TGFb1 in the skin, notably in the dermis. | 02-25-2010 |
| 20100040710 | Stimulation of the synthesis and of the activity of an isoform of lysyl oxidase-like LOXL for stimulating the formation of elastic fibers. - The invention relates to the stimulation of the synthesis and of the activity of an isoform of lysyl oxidase, and more particularly of the LOXL (lysyl oxidase-like) isoform. | 02-18-2010 |
